| SpectraBase Spectrum ID |
Dkbh17cWL1k |
| Name |
1-(4-Chlorobenzyl)-4-(2-dimethylaminoethyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
281.165875485 u |
| Formula |
C15H24ClN3 |
| InChI |
InChI=1S/C15H24ClN3/c1-17(2)7-8-18-9-11-19(12-10-18)13-14-3-5-15(16)6-4-14/h3-6H,7-13H2,1-2H3 |
| InChIKey |
FLZFJUOARRDDTA-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
281.831 g/mol |
| Nominal Mass |
281 u |
| Quality |
942 |
| Retention Index |
2082 |
| SMILES |
C(N1CCN(CC1)CCN(C)C)C=1C=CC(=CC1)Cl |
| SPLASH |
splash10-05i0-9750000000-0f459b59dfff104448d4 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(4-chlorobenzyl)-4-(2-dimethylaminoethyl)
2-(4-(4-chlorobenzyl)piperazin-1-yl)-N,N-dimethylethan-1-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011196 |
